Detalhe da pesquisa
1.
Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer.
World J Urol
; 37(1): 155-163, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905887
2.
Prostaglandin D2 effects and DP1 /DP2 receptor distribution in guinea pig urinary bladder out-flow region.
J Cell Mol Med
; 21(2): 234-243, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664012
3.
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.
Hum Mol Genet
; 23(20): 5545-57, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861552
4.
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
Proc Natl Acad Sci U S A
; 110(43): 17426-31, 2013 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101484
5.
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Int J Cancer
; 137(7): 1621-9, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809917
6.
Localization of P2X receptor subtypes 2, 3 and 7 in human urinary bladder.
BMC Urol
; 15: 81, 2015 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26253104
7.
The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.
Tumour Biol
; 35(5): 4425-34, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24408018
8.
Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21.
J Biol Chem
; 287(13): 9845-9854, 2012 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22311974
9.
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.
Hum Mol Genet
; 20(21): 4268-81, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21750109
10.
Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer.
Nitric Oxide
; 27(3): 185-91, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22819699
11.
Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis.
J Biol Chem
; 285(18): 13658-65, 2010 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20228054
12.
Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer.
Nitric Oxide
; 25(3): 338-43, 2011 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703358
13.
Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis.
Scand J Urol Nephrol
; 45(5): 319-25, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21612325
14.
The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.
J Urol
; 184(5): 2150-7, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20850837
15.
Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients.
Mutat Res
; 694(1-2): 39-44, 2010 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20887739
16.
Diagnostic random bladder biopsies: reflections from a population-based cohort of 538 patients.
Scand J Urol Nephrol
; 44(1): 11-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19958071
17.
Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours.
Cancer Lett
; 241(1): 142-9, 2006 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16343742
18.
FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.
Pharmacol Res Perspect
; 3(5): e00171, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26516583
19.
Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2.
Br J Pharmacol
; 172(16): 4024-37, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25917171
20.
Polymorphisms In The Nitric-Oxide Synthase 2 Gene And Prostate Cancer Pathogenesis.
Redox Biol
; 5: 419, 2015 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28162285